Table 1.
CLR* | Expression | Glycan PAMPs | Pathogenic (exogenous) ligands | Signalling motif or adaptor | Signalling proteins involved | Immunological outcome | Refs |
---|---|---|---|---|---|---|---|
Group II CLRs (asialoglycoprotein receptor family) | |||||||
DC-SIGN (CD209) | Myeloid DCs | High mannose and fucose (LeX, LeY, LeA, LeB) |
˙ Mycobacterium tuberculosis, Mycobacterium leprae, BCG, Lactobacilli spp. and Helicobacter pylori ˙ HIV-1, measles virus, dengue virus, SARS coronavirus and filoviruses ˙ Candida albicans ˙ Leishmania spp. ˙ Tick Ixodes scapularis saliva protein Salp15, peanut allergen Ara h1 and Schistosoma mansoni soluble egg antigens |
None | LSP1, LARG, RhoA, Ras proteins, RAF1, Src kinases and PAKs |
˙ Upregulation of TLR-induced IL-10 production ˙ Induction of TH1, TH2, TH17 and regulatory T cell differentiation‡ ˙ Inhibition of TH1 cell differentiation‡ ˙ Induction of regulatory T cells‡ ˙ Antigen presentation |
3,20,22,26,29,68,85–93 |
Langerin (CLEC4K, CD207) | Langerhans cells and dermal DC subset | High mannose, fucose (LeY, LeB) and GlcNAc |
˙ M. leprae ˙ HIV-1 |
Putative proline-rich domain | ND |
˙ M. leprae endocytosis and antigen presentation ˙ HIV-1 internalization and degradation |
84,94,95 |
MGL (CLEC10A, CD301) | Myeloid DCs and macrophages | Terminal GalNAc (Tn antigen, LDN) |
˙ Filoviruses ˙ S. mansoni |
None | ND | ND | 96 |
CLEC5A (MDL1) | Monocytes and macrophages | ND | Dengue virus | DAP10 and DAP12 | ND | Induction of TNF production | 13,69,97 |
Group II CLRs (asialoglycoprotein receptor family; dectin 1 subfamily) | |||||||
Dectin 1 (CLEC7A) | Myeloid DCs, monocytes, macrophages and B cells | β-1,3-glucan |
˙ M. tuberculosis and Mycobacterium abscessus ˙ C. albicans, Aspergillus fumigatus, Pneumocystis carinii, Penicillium marneffei, Coccidioides posadasii and Histoplasma capsulatum |
YxxL§ | SYK, PLCγ2, CARD9, BCL-10, MALT1, NIK and RAF1 |
˙ Induction of TH1 and TH17 cell differentiation through induction of IL-1β, IL-6, IL-12 and IL-23 production ˙ Induction of TNF and CXCL2 production ˙ Phagocytosis ˙ LTB4 synthesis |
4,5,17,42,43,59,65,98 |
MICL (CLEC12A, DCAL2) | Myeloid DCs, monocytes, macrophages and neutrophils | ND | ND | ITIM | SHP1, SHP2 and ERK | Inhibition of TLR4-induced IL-12 production | 14,16 |
CLEC2 (CLEC1B) | Platelets | ND |
˙ HIV-1 ˙ Snake venom protein rhodocytin |
YxxL§ | SYK, LAT, RAC1 and PLCγ2 | ND | 99–101 |
DNGR1 (CLEC9A) | BDCA3+ DCs, monocytes and B cells | ND | ND | YxxL§ | SYK |
˙ Induction of TNF production ˙ Antigen cross-presentation |
78,82,102 |
CLEC12B | Macrophages | ND | ND | ITIM | SHP1 and SHP2 | ND | 103 |
Group II CLRs (asialoglycoprotein receptor family; DCIR subfamily) | |||||||
Dectin 2 (CLEC6A) | Myeloid DCs, pDCs, monocytes, macrophages, B cells and neutrophils | High mannose |
˙ M. tuberculosis ˙ C. albicans, Trichophyton rubrum, A. fumigatus, Microsporum audouinii and Paracoccoides brasiliensis ˙ House dust mite Dermatophagoides pteronyssinus allergens |
FcRγ | Src kinases and SYK |
˙ Induction of TNF and IL-6 production ˙ Cysteinyl leukotriene synthesis |
10,58 |
BDCA2 (CLEC4C, CD303) | pDCs, monocytes, macrophages and neutrophils | ND | ND | FcRγ | SYK, BTK, BLNK and PLCγ2 |
˙ Inhibition of TLR9-induced type I IFN, TNF and IL-6 production ˙ Upregulation of TLR9-induced IL-10 production |
11,31,33 |
Mincle (CLEC4E) | Myeloid DCs, monocytes and macrophages | α-mannose | Malassezia spp. | FcRγ | SYK and CARD9 | ˙ Induction of TNF, IL-10 and CXCL2 production | 12,18 |
DCIR (CLEC4A) | Myeloid DCs, pDCs, monocytes, macrophages, B cells and neutrophils | ND | HIV-1 | ITIM | SHP1 and SHP2 |
˙ Inhibition of TLR8-induced TNF and IL-12 production ˙ Inhibition of TLR9-induced TNF and IFNα production |
6,15,38 |
Group I CLRs (mannose receptor family) | |||||||
Mannose receptor (CD206) | Myeloid DCs and macrophages | High mannose, fucose and sulphated sugars (sLex) |
˙ M. tuberculosis, Mycobacterium kansasii, Francisella tularensis, Klebsiella pneumoniae and Streptococcus pneumoniae ˙ HIV-1 and dengue virus ˙ C. albicans, Cryptococcus neoformans and P. carinii ˙ Leishmania spp. |
ND | CDC42, RhoB, PAKs and ROCK1 | Phagocytosis and antigen presentation | 104–106 |
DEC205 (LY75, CD205) | Myeloid DCs | ND | ND | ND | ND | Endocytosis and antigen presentation | 76 |
*Alternative names are provided in brackets. | |||||||
‡Effect on T cell differentiation is ligand dependent. | |||||||
§In this motif, x denotes any amino acid. BCG, Mycobacterium bovis bacillus Calmette–Guérin; BCL-10, B cell lymphoma 10; BDCA, blood dendritic cell antigen protein; BLNK, B cell linker; BTK, Bruton's tyrosine kinase; CARD9; caspase-recruitment domain family, member 9; CDC42, cyclin-dependent kinase 42; CLEC, C-type lectin domain family member; CLR, C-type lectin receptor; CXCL2, CXC-chemokine ligand 2; DC, dendritic cell; DCIR, DC immunoreceptor; DC-SIGN, DC-specific ICAM3-grabbing non-integrin; dectin, DC-associated C-type lectin; ERK, extracellular signal-regulated kinase; FcRγ, Fc receptor γ-chain; GalNAc, N-acetylgalactosamine; GlcNAc, β1,6-N-acetylglucosamine; IL, interleukin; ITIM, immunoreceptor tyrosine-based inhibitory motif; LARG, leukaemia-associated Rho guanine nucleotide exchange factor; LAT, linker for activation of T cells; LSP1, lymphocyte-specific 1; LTB4, leukotriene B4; MALT1, mucosa-associated lymphoid tissue lymphoma translocation gene; MICL, C-type lectin-like receptor; mincle, macrophage-inducible C-type lectin; ND, not determined; NIK, nuclear factor-κB-inducing kinase; PAK, p21-activated kinase; PAMP, pathogen-associated molecular pattern; pDC, plasmacytoid DC; PLCγ2; phospholipase Cγ2; RHO, Ras homologue; ROCK1, Rho-associated coiled-coil-containing protein kinase 1; SARS, severe acute respiratory syndrome; SHP, SH2-domain-containing protein tyrosine phosphatase; sLe, sialyl Lewis; SYK, spleen tyrosine kinase; TLR, Toll-like receptor; TH, T helper; TNF, tumour necrosis factor. |